The continuous conversion from non-toxic normal cellular PrPc to highly neurotoxic PrPSc coupled with early neuroinflammation and later neurodegeneration makes it complicated to develop an efficient therapy for prion diseases [43]. Here, PRNP is linked to prion disease.